assay
≥99.0% (HPLC)
optical activity
[α]20/D −3.1±0.3°, c = 2% in 0.1 M HCl
mp
204-208 °C (dec.), 210 °C (dec.) (lit.)
storage temp.
2-8°C
SMILES string
N[C@@H](Cc1ccc(O)c(I)c1)C(O)=O
InChI
1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1
InChI key
UQTZMGFTRHFAAM-ZETCQYMHSA-N
Biochem/physiol Actions
酪氨酸羟化酶抑制剂。
Other Notes
Inhibitor (Ki ~ 500 nM) of tyrosine hydroxylase
法规信息
新产品
此项目有
G A Smythe et al.
The Journal of clinical endocrinology and metabolism, 40(4), 714-716 (1975-04-01)
Oral administration of a single 1 g dose of MIT to 10 normal male and female subjects resulted in a rise in serum prolactin in each subject. The mean peak level of serum prolactin attained by the 10 subjects was
K Painter et al.
Clinical chemistry, 25(5), 797-799 (1979-05-01)
Although there is abundant published evidence that radioiodinated antigens interfere in digoxin radioimmunoassays, other radioimmunoassays are similarly affected. We investigated the relationship of radioiodinated antigen structure to its function in the immunoassay. Carrier-free 125I-labeled iodotyrosine and iodohistamine derivatives were incubated
E E Müller et al.
Drugs, 25(4), 399-432 (1983-04-01)
Drugs whose systemic and/or central administration induce suppression or stimulation of prolactin secretion are reviewed. The most commonly used prolactin-lowering drugs include: (a) direct-acting dopamine receptor agonists (e.g. dopamine, apomorphine and the ergot derivatives); (b) indirect-acting dopamine agonists (e.g. amphetamine
M.K. Jain
Handbook of Enzyme Inhibitors, 362-362 (1982)
R. Shiman et al.
Methods in Enzymology, 17A, 609-609 (1970)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持